Rokib Masud

Array ( [id] => 4324369 [patent_doc_number] => 06331621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Isolated nucleic acid molecules which encode activin-receptor like kinases, expression vectors and cells containing these' [patent_app_type] => 1 [patent_app_number] => 9/679187 [patent_app_country] => US [patent_app_date] => 2000-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 28985 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331621.pdf [firstpage_image] =>[orig_patent_app_number] => 679187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490645 [patent_doc_number] => 06417177 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Chloroquine derivatives for the treatment of Parkinson\'s disease' [patent_app_type] => B1 [patent_app_number] => 09/615639 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6983 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417177.pdf [firstpage_image] =>[orig_patent_app_number] => 09615639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602499 [patent_doc_number] => 06432678 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Macaca cynomolgus IL 18' [patent_app_type] => B1 [patent_app_number] => 09/597576 [patent_app_country] => US [patent_app_date] => 2000-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9058 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432678.pdf [firstpage_image] =>[orig_patent_app_number] => 09597576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1496094 [patent_doc_number] => 06403770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Antibodies to neutrokine-alpha' [patent_app_type] => B1 [patent_app_number] => 09/589287 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 11 [patent_no_of_words] => 162496 [patent_no_of_claims] => 292 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403770.pdf [firstpage_image] =>[orig_patent_app_number] => 09589287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369976 [patent_doc_number] => 06562579 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Diagnostic methods using antibodies to Neutrokine-alpha' [patent_app_type] => B1 [patent_app_number] => 09/588947 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 168191 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562579.pdf [firstpage_image] =>[orig_patent_app_number] => 09588947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1487513 [patent_doc_number] => 06428967 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'LDL receptor signaling pathways' [patent_app_type] => B1 [patent_app_number] => 09/562737 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32192 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428967.pdf [firstpage_image] =>[orig_patent_app_number] => 09562737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422203 [patent_doc_number] => 06506884 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Variant of vascular endothelial growth factor' [patent_app_type] => B1 [patent_app_number] => 09/519476 [patent_app_country] => US [patent_app_date] => 2000-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12888 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506884.pdf [firstpage_image] =>[orig_patent_app_number] => 09519476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1578497 [patent_doc_number] => 06448221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Methods of promoting blood flow within the vasculature of a mammal' [patent_app_type] => B1 [patent_app_number] => 09/506855 [patent_app_country] => US [patent_app_date] => 2000-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 22380 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448221.pdf [firstpage_image] =>[orig_patent_app_number] => 09506855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489825 [patent_doc_number] => 06416954 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Modulating Th2 cell levels via vMIP-I/CCR8 interaction' [patent_app_type] => B1 [patent_app_number] => 09/496675 [patent_app_country] => US [patent_app_date] => 2000-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9307 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416954.pdf [firstpage_image] =>[orig_patent_app_number] => 09496675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1576734 [patent_doc_number] => 06447766 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Method of mobilizing hematopoietic stem cells' [patent_app_type] => B1 [patent_app_number] => 09/467155 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6155 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/447/06447766.pdf [firstpage_image] =>[orig_patent_app_number] => 09467155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636765 [patent_doc_number] => 06379890 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Method for determining asthma susceptibility' [patent_app_type] => B1 [patent_app_number] => 09/459158 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 7556 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379890.pdf [firstpage_image] =>[orig_patent_app_number] => 09459158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567078 [patent_doc_number] => 06376541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Upregulation of endogenous prostaglandins to lower intraocular pressure' [patent_app_type] => B1 [patent_app_number] => 09/445320 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3604 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376541.pdf [firstpage_image] =>[orig_patent_app_number] => 09445320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493390 [patent_doc_number] => 06403096 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof' [patent_app_type] => B1 [patent_app_number] => 09/443061 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 9673 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403096.pdf [firstpage_image] =>[orig_patent_app_number] => 09443061 [rel_patent_id] =>[rel_patent_doc_number] =>)